Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TL-118 + Gemcitabine in Metastatic Pancreatic Cancer
NCT01509911Phase 2Unknown
- Sponsor
- Tiltan Pharma
- Start
- Jan 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TL-118, sponsored by Tiltan Pharma. Status: unknown.
02
Drugs
TL-118
Beyond the preview
Go deeper on NCT01509911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509911.